Pharmaceutics 2013, 5(2), 277-293; doi:10.3390/pharmaceutics5020277
Article

Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles

1 School of Pharmacy, the University of Queensland, Brisbane, QLD 4072, Australia 2 Department of Pharmacy, King's College London, London SE1 8WA, UK 3 Food Science and Technology Program, Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia 4 Centre for Nutrition and Food Sciences, Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, QLD 4072, Australia 5 Australian Institute for Bioengineering and Nanotechnology, and School of Chemical Engineering, The University of Queensland, Brisbane, QLD 4072, Australia
* Author to whom correspondence should be addressed.
Received: 4 February 2013; in revised form: 29 April 2013 / Accepted: 3 May 2013 / Published: 10 May 2013
(This article belongs to the Special Issue Prodrugs)
PDF Full-text Download PDF Full-Text [682 KB, uploaded 10 May 2013 19:27 CEST]
Abstract: Zein was investigated for use as an oral-drug delivery system by loading prednisolone into zein microparticles using coacervation. To investigate the adaptability of this method to other drugs, zein microparticles were loaded with hydrocortisone, which is structurally related to prednisolone; or mesalazine, which is structurally different having a smaller LogP and ionizable functional groups. Investigations into the in vitro digestibility, and the electrophoretic profile of zein, and zein microparticles were conducted to shed further insight on using this protein as a drug delivery system. Hydrocortisone loading into zein microparticles was comparable with that reported for prednisolone, but mesalazine loading was highly variable. Depending on the starting quantities of hydrocortisone and zein, the average amount of microparticles equivalent to 4 mg hydrocortisone, (a clinically used dose), ranged from 60–115 mg, which is realistic and practical for oral dosing. Comparatively, an average of 2.5 g of microparticles was required to deliver 250 mg of mesalazine (a clinically used dose), so alternate encapsulation methods that can produce higher and more precise mesalazine loading are required. In vitro protein digestibility revealed that zein microparticles were more resistant to digestion compared to the zein raw material, and that individual zein peptides are not preferentially coacervated into the microparticles. In combination, these results suggest that there is potential to formulate a delivery system based on zein microparticles made using specific subunits of zein that is more resistant to digestion as starting material, to deliver drugs to the lower gastrointestinal tract.
Keywords: maize; microparticles; protein; drug loading; in vitro digestibility; electrophoresis

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Lau, E.T.L.; Giddings, S.J.; Mohammed, S.G.; Dubois, P.; Johnson, S.K.; Stanley, R.A.; Halley, P.J.; Steadman, K.J. Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles. Pharmaceutics 2013, 5, 277-293.

AMA Style

Lau ETL, Giddings SJ, Mohammed SG, Dubois P, Johnson SK, Stanley RA, Halley PJ, Steadman KJ. Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles. Pharmaceutics. 2013; 5(2):277-293.

Chicago/Turabian Style

Lau, Esther T.L.; Giddings, Steven J.; Mohammed, Salmaan G.; Dubois, Paul; Johnson, Stuart K.; Stanley, Roger A.; Halley, Peter J.; Steadman, Kathryn J. 2013. "Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles." Pharmaceutics 5, no. 2: 277-293.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert